- Home
- CLGN vs LTRN Comparison
CLGN vs LTRN Comparison
Compare CLGN & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- LTRN
- Stock Information
- Founded
- CLGN 2004
- LTRN 2013
- Country
- CLGN Israel
- LTRN United States
- Employees
- CLGN N/A
- LTRN N/A
- Industry
- CLGN Industrial Specialties
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- LTRN Health Care
- Exchange
- CLGN Nasdaq
- LTRN Nasdaq
- Market Cap
- CLGN 33.8M
- LTRN 36.0M
- IPO Year
- CLGN N/A
- LTRN 2020
- Fundamental
- Price
- CLGN $2.66
- LTRN $3.81
- Analyst Decision
- CLGN Strong Buy
- LTRN Strong Buy
- Analyst Count
- CLGN 2
- LTRN 1
- Target Price
- CLGN $11.50
- LTRN $25.00
- AVG Volume (30 Days)
- CLGN 30.5K
- LTRN 73.6K
- Earning Date
- CLGN 08-20-2025
- LTRN 11-06-2025
- Dividend Yield
- CLGN N/A
- LTRN N/A
- EPS Growth
- CLGN N/A
- LTRN N/A
- EPS
- CLGN N/A
- LTRN N/A
- Revenue
- CLGN $2,402,000.00
- LTRN N/A
- Revenue This Year
- CLGN $1,617.28
- LTRN N/A
- Revenue Next Year
- CLGN $83.54
- LTRN N/A
- P/E Ratio
- CLGN N/A
- LTRN N/A
- Revenue Growth
- CLGN 248.62
- LTRN N/A
- 52 Week Low
- CLGN $1.31
- LTRN $2.55
- 52 Week High
- CLGN $5.00
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- CLGN 52.88
- LTRN 39.37
- Support Level
- CLGN $2.38
- LTRN $3.74
- Resistance Level
- CLGN $2.77
- LTRN $4.26
- Average True Range (ATR)
- CLGN 0.18
- LTRN 0.31
- MACD
- CLGN -0.02
- LTRN -0.06
- Stochastic Oscillator
- CLGN 47.46
- LTRN 7.59
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.